Anticoagulation Management for Mechanical Mitral Valve Patients Undergoing Orthopedic Surgery

Preoperative Anticoagulation Management

The American College of Cardiology recommends bridging anticoagulation with therapeutic-dose unfractionated heparin or low-molecular-weight heparin during the perioperative period when INR is subtherapeutic for patients with mechanical mitral valves undergoing orthopedic surgery, with careful consideration of bleeding risk 1, 2, 3
Stop warfarin 3-4 days before surgery to allow INR to fall to <1.5 for major orthopedic procedures, as recommended by the American Heart Association 4, 5, 2, 3
The anticoagulant effect of warfarin persists 48-72 hours after stopping due to inhibition of multiple coagulation proteins, according to the American Heart Association 6

Mechanical mitral valves carry the highest thrombotic risk and warrant bridging regardless of additional risk factors, as stated by the American College of Cardiology 4, 5, 1, 3
Start bridging when INR falls below 2.0-2.5, typically 36-48 hours before surgery, as recommended by the American College of Cardiology 2, 3

Administer 4-factor prothrombin complex concentrate for urgent reversal of warfarin, as preferred by the American Heart Association over fresh frozen plasma for faster reversal 4, 5, 1
Add intravenous vitamin K 5-10 mg for urgent reversal, but avoid high-dose vitamin K as it significantly delays return to therapeutic anticoagulation postoperatively, according to the American Heart Association 4, 5, 6

Resume warfarin 12-24 hours postoperatively once hemostasis is achieved and bleeding risk is acceptable, as recommended by the American Heart Association 4, 5, 2, 6, 7
Restart warfarin at the patient's previous therapeutic dose, according to the American Heart Association 7

The American College of Cardiology states that mechanical mitral valves automatically place patients in the highest thrombotic risk category, regardless of other factors 4, 5, 1, 8

The American College of Cardiology advises against using direct oral anticoagulants in mechanical valve patients, as they are contraindicated and associated with increased thrombotic and bleeding complications 2
Avoid giving high-dose vitamin K routinely for INR reversal, as this creates difficulty re-establishing therapeutic anticoagulation and may induce a hypercoagulable state, according to the American Heart Association 4, 5, 6, 8